# SHAPE Neoadjuvant Chemotherapy Response

> **NCT04715958** · PHASE2,PHASE3 · RECRUITING · sponsor: **Kibo Nam** · enrollment: 200 (estimated)

## Conditions studied

- Anatomic Stage III Breast Cancer AJCC v8
- Locally Advanced Breast Carcinoma

## Interventions

- **PROCEDURE:** Contrast-Enhanced Ultrasound
- **DRUG:** Perflutren Lipid Microspheres
- **PROCEDURE:** Ultrasound

## Key facts

- **NCT ID:** NCT04715958
- **Lead sponsor:** Kibo Nam
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-12-07
- **Primary completion:** 2026-10-31
- **Final completion:** 2026-10-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-04-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04715958

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04715958, "SHAPE Neoadjuvant Chemotherapy Response". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04715958. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*